文献检索
文档翻译
深度研究
Zotero 插件
邀请有礼
套餐&价格
历史记录
Suppr
超能文献
应用&插件
Aliskiren + hydrochlorothiazide.
出版信息
Prescrire Int. 2010 Apr;19(106):64.
PMID:
20568486
Abstract
摘要
文献AI研究员
20分钟写一篇综述,助力文献阅读效率提升50倍。
立即体验
用中文搜PubMed
大模型驱动的PubMed中文搜索引擎
马上搜索
文档翻译
学术文献翻译模型,支持多种主流文档格式。
立即体验
应用&插件
Zotero 插件
浏览器插件
Mac 客户端
Windows 客户端
微信小程序
定价
高级版会员
购买积分包
购买API积分包
服务
文献检索
文档翻译
深度研究
API 文档
关于我们
关于 Suppr
公司介绍
联系我们
用户协议
隐私条款
关注我们
Suppr 超能文献
核心技术专利:
CN118964589B
侵权必究
粤ICP备2023148730 号-1
Suppr @ 2025
相似文献
1
Aliskiren + hydrochlorothiazide.
Prescrire Int. 2010 Apr;19(106):64.
2
Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.
Circulation. 2009 Jan 27;119(3):417-25. doi: 10.1161/CIRCULATIONAHA.107.750745. Epub 2009 Jan 12.
3
Aliskiren/amlodipine (Tekamlo): another combination tablet for hypertension.
Med Lett Drugs Ther. 2010 Nov 29;52(1352):94-5.
4
In brief: Another three-drug combination for hypertension.
Med Lett Drugs Ther. 2011 Apr 4;53(1361):28.
5
The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
Rev Cardiovasc Med. 2007;8 Suppl 2:S22-30.
6
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
J Hypertens. 2008 Mar;26(3):589-99. doi: 10.1097/HJH.0b013e3282f3ad9a.
7
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
Am J Hypertens. 2007 Jan;20(1):11-20. doi: 10.1016/j.amjhyper.2006.06.003.
8
Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
J Hypertens. 2007 Jan;25(1):217-26. doi: 10.1097/HJH.0b013e3280103a6b.
9
Aliskiren-hydrochlorothiazide combination for the treatment of hypertension.
Expert Rev Cardiovasc Ther. 2008 Mar;6(3):305-14. doi: 10.1586/14779072.6.3.305.
10
Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
Int J Clin Pract. 2006 Nov;60(11):1343-56. doi: 10.1111/j.1742-1241.2006.01164.x.